AlphaGen Therapeutics

A New Era of Alpha

United States · Founded 2023

Founded
2023
Business Model
B2B
Last Round
Series AAug 2025
Rounds
2

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

AlphaGen Therapeutics is pioneering the discovery, development and commercialization of innovative radioligand therapies. With its technology platform, the company is developing a new class of alpha radioligand therapies for patients in China and around the world. AlphaGen has secured a next-generation Pb-212 isolation technology that it positions as the basis for a radiopharmaceutical platform, citing an improved therapeutic window, abundant raw material supply, and lower radiation activity for broader hospital access. It partners with biotech and pharmaceutical companies, academic research institutions, and health systems to accelerate development and improve patient access.

Summary

AlphaGen Therapeutics is a Biotech company based in United States, founded in 2023. Its most recent funding was a Series A round in Aug 2025. Investors include Eight Roads Ventures and F-Prime Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AAug 2025

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AlphaGen Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alphagen-therapeutics"><img src="https://indexed.vc/api/badge/company/alphagen-therapeutics" alt="AlphaGen Therapeutics on Indexed.vc" width="260" height="76" /></a>